Eiger BioPharmaceuticals' Core ValuesWe are a values-driven company that works to embody Integrity, Passion, Accountabilitity, Creativity, and Teamwork in the pursuit of our mission.
SpotlightEiger BioPharmaceuticals Announces Key Operational Hires to Senior Management Team: Jim Welch, Chief Financial Officer & Jim Shaffer, Chief Business Officer
The Lancet Infectious Diseases Journal Publishes Results of Phase 2 Study of Lonafarnib in Hepatitis Delta Virus (HDV) Infected Patients
In the NewsEiger BioPharmaceuticals Announces Senior Staff Appointments in Clinical Development and Regulatory Affairs: Dr Joanne Quan, M.D., as Chief Medical Officer & Dr Shelly Xiong, Ph.D., as Vice President of Regulatory Affairs
Eiger Bio Receives Orphan Designation for Lonafarnib, a First In Class, Investigational Treatment for Hepatitis Delta Virus (HDV) Infection